Abstract
PURPOSE OF REVIEW: To describe and bring together recent development in the diagnosis and treatment of both community-acquired and opportunistic fungal infections in the intensive care unit. RECENT FINDINGS: The past few years have brought major advances to both the diagnosis and treatment of fungal infections. The development of newer therapeutic modalities to supplement existing treatment options includes a new class of antifungal agents, the echinocandins. Newer and improved agents of the azole class have arrived as well as better delineation for the role of liposomal amphotericins. Newer, nonculture-based diagnostic tests have allowed earlier, more timely diagnosis of opportunistic fungal infections, allowing more rapid initiation of therapy. SUMMARY: Improved diagnostic tests and newer antifungal agents have been introduced, leading to earlier diagnosis and treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 464-469 |
Number of pages | 6 |
Journal | Current Opinion in Critical Care |
Volume | 12 |
Issue number | 5 |
DOIs | |
State | Published - Oct 1 2006 |
Keywords
- Aspergillosis
- Azoles
- Candidiasis
- Coccidioidomycosis
- Echinocandins
- Fungal infection